Rapport Therapeutics CEO Abraham Ceesay disposes of $143,276 in common shares
RAPP•CEO Abraham Ceesay sold 4,522 Rapport Therapeutics common shares for a total of $143,276 on Oct. 6-7. His directly held stake fell to 452,245 shares after the Oct. 7 sale.
1. Share sales
Ceesay sold shares at $32.0314 each on Oct. 6 and $30.66 each on Oct. 7. Following the Oct. 7 sale, he directly held 452,245 shares.
